<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01022632</url>
  </required_header>
  <id_info>
    <org_study_id>Pharmacol no.01 /2008 Research</org_study_id>
    <nct_id>NCT01022632</nct_id>
  </id_info>
  <brief_title>Effect of Curcumin as Nutraceutical in Patients of Depression</brief_title>
  <official_title>A Randomized, Active Controlled, Open Label, Parallel Group Study to Compare the Efficacy of Extract of Curcuma Longa (Turmeric) With Fluoxetine and to Study Its Effect as an Add on Therapy to Fluoxetine in Patients of Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Government Medical College, Bhavnagar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Health and Family Welfare Department, Government of Gujarat, India</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Arjuna Natural Extracts Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Government Medical College, Bhavnagar</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to find the effect of commonly used nutraceutical curcumin (
      extract of Curcuma longa, commonly called 'Haldi' in Hindi) in patients of depression.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Response rate according to HAM-D17 scale</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean change in HAM-D17 score</measure>
    <time_frame>Six weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical global impression assessment</measure>
    <time_frame>Six Weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global efficacy at the end of study</measure>
    <time_frame>Six weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in laboratory parameters (routine hematology and urine)</measure>
    <time_frame>Six weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Fluoxetine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fluoxetine : 20 mg Once a day in morning after taking food for 6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Curcumin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Curcumin 500 mg 12 hourly after taking food in morning and evening for 6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Curcumin and Fluoxetine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Curcumin 500 12 hourly after taking food in morning and evening and Fluoxetine 20 mg Once a day in morning after taking food for 6 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Curcumin</intervention_name>
    <description>Curcumin 500 mg 12 hourly after taking food in morning and evening for 6 weeks</description>
    <arm_group_label>Curcumin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluoxetine</intervention_name>
    <description>Fluoxetine ; 20 mg Once a day in morning after taking food for 6 weeks</description>
    <arm_group_label>Fluoxetine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Curcumin and Fluoxetine</intervention_name>
    <description>Curcumin 500 12 hourly after taking food in morning and evening and Fluoxetine 20 mg Once a day in morning after taking food for 6 weeks</description>
    <arm_group_label>Curcumin and Fluoxetine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Depression as diagnosed under DSM-IV Axis I Disorders.

          -  Score greater than 7 but less then 35 on the 17-item Hamilton Depression (HAM-D) Scale
             at screening.

          -  The patient has relative(s) to care for him/her

          -  Informed consent obtained from the patient or relative

        Exclusion Criteria:

          -  Scores greater than 2 on the &quot;suicide&quot; item of HAM-D, or history of suicide attempt(s)
             in the past 12 months.

          -  Current suicidal or homicidal risk, as determined by the investigator.

          -  Clinically significant liver disease (such as hepatitis, cirrhosis, etc); or
             clinically significant elevation of liver enzyme tests (two times the upper limit of
             normal.

          -  History of seizure disorder (other than febrile).

          -  Patient who has had monoamine oxidase inhibitor , any selective serotonin reuptake
             inhibitor or any other antidepressant in last 15 days

          -  Any of the following DSM-IV diagnoses current (within past 3 months) schizophrenia,
             schizo-affective, or other psychotic disorder; bipolar disorder; current panic
             disorder or obsessive compulsive disorder; history of psychotic features of affective
             disorder (mood congruent or incongruent)

          -  Patient with history of untreated or unstable thyroid disorder

          -  Failed to respond to at least two adequate antidepressant trials (defined as 6 weeks
             or more treatment with either greater than or equal to 150 mg imipramine, or tricyclic
             equivalent), or greater than or equal to 60 mg of phenelzine, or MAOI equivalent, or
             greater than or equal to 100 mg of sertraline, or its SSRI equivalent.

          -  Have had other investigational drugs within 30 days or other psychotropic medication
             within 21 days.

          -  Known allergy or hypersensitivity to the study medications.

          -  Receiving psychotherapies which are specifically designed to treat depression, eg,
             interpersonal psychotherapy during the study period.

          -  Mental retardation or cognitive impairment, or any disorder that might interfere with
             their ability to give consent or follow study procedures and requirements.

          -  In case of female patients, Abstinence or effective method of contraception throughout
             the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Bharat Panchal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor and Head, Department of Psychiatry, Sir T. General Hospital and Government Medical College, Bhavnagar-364001, Gujarat, India</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sir Takthasinhji General Hospital</name>
      <address>
        <city>Bhavnagar</city>
        <state>Gujarat</state>
        <zip>364001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2009</study_first_submitted>
  <study_first_submitted_qc>November 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2009</study_first_posted>
  <last_update_submitted>January 27, 2010</last_update_submitted>
  <last_update_submitted_qc>January 27, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. C. B. Tripathi, Professor and Head , Department of Pharmacology</name_title>
    <organization>Government Medical College, Bhavnagar-364001, Gujarat, India</organization>
  </responsible_party>
  <keyword>Depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluoxetine</mesh_term>
    <mesh_term>Curcumin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

